Ensign Peak Advisors’s Ascendis Pharma ASND Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $10.7M | Hold |
61,724
| – | – | 0.02% | 453 |
|
|
2025
Q1 | $9.62M | Buy |
61,724
+59,501
| +2,677% | +$9.27M | 0.02% | 475 |
|
|
2024
Q4 | $306K | Sell |
2,223
-760
| -25% | -$105K | ﹤0.01% | 1673 |
|
|
2024
Q3 | $445K | Sell |
2,983
-108
| -3% | -$16.1K | ﹤0.01% | 1637 |
|
|
2024
Q2 | $422K | Sell |
3,091
-64,453
| -95% | -$8.79M | ﹤0.01% | 1641 |
|
|
2024
Q1 | $10.2M | Hold |
67,544
| – | – | 0.02% | 443 |
|
|
2023
Q4 | $8.51M | Hold |
67,544
| – | – | 0.02% | 480 |
|
|
2023
Q3 | $6.32M | Sell |
67,544
-149
| -0.2% | -$14K | 0.01% | 506 |
|
|
2023
Q2 | $6.04M | Hold |
67,693
| – | – | 0.01% | 538 |
|
|
2023
Q1 | $7.26M | Hold |
67,693
| – | – | 0.02% | 470 |
|
|
2022
Q4 | $8.27M | Buy |
67,693
+44,650
| +194% | +$5.45M | 0.02% | 457 |
|
|
2022
Q3 | $2.38M | Hold |
23,043
| – | – | 0.01% | 727 |
|
|
2022
Q2 | $2.14M | Buy |
23,043
+6,237
| +37% | +$580K | 0.01% | 775 |
|
|
2022
Q1 | $1.97M | Sell |
16,806
-3,475
| -17% | -$408K | ﹤0.01% | 897 |
|
|
2021
Q4 | $2.73M | Buy |
20,281
+2,596
| +15% | +$349K | 0.01% | 851 |
|
|
2021
Q3 | $2.82M | Sell |
17,685
-11,000
| -38% | -$1.75M | 0.01% | 919 |
|
|
2021
Q2 | $3.77M | Sell |
28,685
-38,197
| -57% | -$5.03M | 0.01% | 774 |
|
|
2021
Q1 | $8.62M | Buy |
66,882
+28,537
| +74% | +$3.68M | 0.02% | 458 |
|
|
2020
Q4 | $6.4M | Sell |
38,345
-12,695
| -25% | -$2.12M | 0.01% | 530 |
|
|
2020
Q3 | $7.88M | Buy |
51,040
+5,371
| +12% | +$829K | 0.02% | 492 |
|
|
2020
Q2 | $6.76M | Buy |
45,669
+2,711
| +6% | +$401K | 0.02% | 520 |
|
|
2020
Q1 | $4.84M | Sell |
42,958
-6,356
| -13% | -$716K | 0.02% | 519 |
|
|
2019
Q4 | $6.86M | Buy |
+49,314
| New | +$6.86M | 0.02% | 549 |
|